ASCO is one of the world’s leading cancer conferences, where groundbreaking research and treatment advances are discussed. But with so much information coming out at once, it can be hard to know what truly matters. We were grateful to Dr. Kari Hacker, gynecologic oncologist at the UNC Lineberger Comprehensive Cancer Center, for joining our recent webinar where she answered patient questions about the innovation unveiled at ASCO 2026.
During the webinar, we discussed:
- The biggest ovarian cancer headlines from ASCO 2026
- Promising new treatments and clinical trial updates
- What’s new in targeted therapies and immunotherapy
- What these developments could mean for your care
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.
